MTOR and hepatoblastoma: mTOR inhibitors blocked hepatoblastoma growth in vitro and in xenograft models91,92, and one clinical study showed that two hepatoblastoma patients treated with the mTOR inhibitor everolimus after liver transplantation did not develop any metastases93.